Principal Financial Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,602
Closed -$27.4K 2535
2023
Q1
$27.4K Buy
23,602
+2,677
+13% +$4.89K ﹤0.01% 2409
2022
Q4
$56.1K Buy
20,925
+7,273
+53% +$19.2K ﹤0.01% 2361
2022
Q3
$39K Buy
13,652
+3,144
+30% +$13.4K ﹤0.01% 2427
2022
Q2
$53K Buy
+10,508
New +$55K ﹤0.01% 2457
2021
Q4
Sell
-10,185
Closed -$199K 2670
2021
Q3
$199K Buy
10,185
+2,519
+33% +$95.8K ﹤0.01% 2433
2021
Q2
$344K Buy
+7,666
New +$355K ﹤0.01% 2314

Other funds holding CELL

Principal Financial Group's CELL Position: Q2 2023 in Review

Principal Financial Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 23,602 shares — an estimated $27.4K sold.

Principal Financial Group first reported a position in CELL in Q2 2021 and held it in 6 quarters. The position peaked at $344K in Q2 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Principal Financial Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Principal Financial Group sold 23,602 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $27.4K.
  • Principal Financial Group first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Principal Financial Group's PhenomeX Inc. Common Stock position peaked at $344K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Principal Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.